Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study

BACKGROUND: Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies is the potential for buprenorphine diversion. However, the population-level effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Joëlla W., Duprey, Michael, Khan, Sazid, Cance, Jessica, Rice, Donald P., Bobashev, Georgiy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580611/
https://www.ncbi.nlm.nih.gov/pubmed/37848945
http://dx.doi.org/10.1186/s12954-023-00888-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580611/
https://www.ncbi.nlm.nih.gov/pubmed/37848945
http://dx.doi.org/10.1186/s12954-023-00888-6

Ejemplares similares